Reuters logo
BRIEF-‍Nanostring and NSABP Foundation enter into agreement to study immunophenotypes in colorectal cancer​
October 26, 2017 / 10:42 AM / a month ago

BRIEF-‍Nanostring and NSABP Foundation enter into agreement to study immunophenotypes in colorectal cancer​

Oct 26 (Reuters) - Nanostring Technologies Inc:

* ‍Nanostring and NSABP foundation enter into agreement to study immunophenotypes in colorectal cancer​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below